| NCT04440943 |
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT04440943 |
Recruiting |
Celldex Therapeutics |
2022-03-31 |
| NCT04430842 |
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S |
https://ClinicalTrials.gov/show/NCT04430842 |
Recruiting |
Quadriga Biosciences, Inc. |
2021-09-30 |
| NCT04137289 |
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT04137289 |
Recruiting |
Boehringer Ingelheim |
2023-04-04 |
| NCT03829436 |
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT03829436 |
Recruiting |
Tempest Therapeutics |
2022-02-18 |
| NCT03377179 |
A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03377179 |
Recruiting |
RedHill Biopharma Limited |
2022-12-31 |
| NCT03368963 |
TAS102 in Combination With NAL-IRI in Advanced GI Cancers |
https://ClinicalTrials.gov/show/NCT03368963 |
Recruiting |
Emory University |
2021-11-28 |
| NCT03364530 |
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03364530 |
Recruiting |
University Hospital, Montpellier |
2022-06-30 |
| NCT03820310 |
Clinical Trial of Autologous Tcm Immunotherapy in ICC |
https://ClinicalTrials.gov/show/NCT03820310 |
Recruiting |
Newish Technology (Beijing) Co., Ltd. |
2021-04-30 |
| NCT03345303 |
Bortezomib in Intrahepatic Cholangiocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT03345303 |
Recruiting |
Eastern Hepatobiliary Surgery Hospital |
2020-12-31 |
| NCT03339843 |
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib |
https://ClinicalTrials.gov/show/NCT03339843 |
Recruiting |
Jules Bordet Institute |
2021-10-15 |
| NCT03338062 |
A Pilot Study to Assess Theragnostically Planned Liver Radiation With Functional DVH Analysis to Optimize Individualized Radiation Therapy |
https://ClinicalTrials.gov/show/NCT03338062 |
Completed |
Indiana University |
2019-09-02 |
| NCT03278106 |
TAS-102 in Treating Advanced Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03278106 |
Active, not recruiting |
Mayo Clinic |
2018-11-30 |
| NCT03267966 |
Margin Status After Pancreaticoduodenectomy for Cancer |
https://ClinicalTrials.gov/show/NCT03267966 |
Completed |
Campus Bio-Medico University |
2015-06-30 |
| NCT03257761 |
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT03257761 |
Recruiting |
University of Southern California |
2021-02-07 |
| NCT03251443 |
A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03251443 |
Completed |
Peking Union Medical College Hospital |
2019-03-08 |
| NCT03250273 |
A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03250273 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-11-30 |
| NCT03230318 |
Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03230318 |
Recruiting |
Basilea Pharmaceutica |
2020-07-31 |
| NCT03212274 |
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations |
https://ClinicalTrials.gov/show/NCT03212274 |
Recruiting |
National Cancer Institute (NCI) |
2020-07-31 |
| NCT03207347 |
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) |
https://ClinicalTrials.gov/show/NCT03207347 |
Recruiting |
University of Florida |
2021-12-31 |
| NCT03201458 |
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT03201458 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-06-30 |
| NCT03150615 |
Enteral Nutrition After Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT03150615 |
Completed |
Nanjing Medical University |
2017-12-31 |
| NCT03149549 |
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors |
https://ClinicalTrials.gov/show/NCT03149549 |
Recruiting |
CytomX Therapeutics |
2019-12-31 |
| NCT03144661 |
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies |
https://ClinicalTrials.gov/show/NCT03144661 |
Recruiting |
Incyte Corporation |
2021-02-28 |
| NCT03139487 |
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03139487 |
Recruiting |
Asan Medical Center |
2021-09-30 |
| NCT03111732 |
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) |
https://ClinicalTrials.gov/show/NCT03111732 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT03086993 |
Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03086993 |
Recruiting |
Delcath Systems Inc. |
2023-01-31 |
| NCT03079427 |
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03079427 |
Recruiting |
Asan Medical Center |
2021-04-30 |
| NCT03058289 |
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 |
https://ClinicalTrials.gov/show/NCT03058289 |
Recruiting |
Intensity Therapeutics, Inc. |
2022-07-31 |
| NCT03043547 |
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies |
https://ClinicalTrials.gov/show/NCT03043547 |
Recruiting |
AIO-Studien-gGmbH |
2021-01-31 |
| NCT03042182 |
Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03042182 |
Recruiting |
Immunitor LLC |
2020-02-20 |
| NCT03027284 |
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT03027284 |
Completed |
Eli Lilly and Company |
2019-06-20 |
| NCT03003065 |
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers |
https://ClinicalTrials.gov/show/NCT03003065 |
Recruiting |
Chinese University of Hong Kong |
2022-08-31 |
| NCT02999672 |
A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors |
https://ClinicalTrials.gov/show/NCT02999672 |
Completed |
Hoffmann-La Roche |
2018-04-10 |
| NCT02990481 |
A Study of TRK-950 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02990481 |
Recruiting |
Toray Industries, Inc |
2021-03-31 |
| NCT02989857 |
Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy) |
https://ClinicalTrials.gov/show/NCT02989857 |
Active, not recruiting |
Agios Pharmaceuticals, Inc. |
2019-01-31 |
| NCT02958059 |
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient |
https://ClinicalTrials.gov/show/NCT02958059 |
Recruiting |
Yonsei University |
2020-08-31 |
| NCT02924376 |
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202) |
https://ClinicalTrials.gov/show/NCT02924376 |
Active, not recruiting |
Incyte Corporation |
2020-11-12 |
| NCT02878473 |
Liver Transplantation for Early Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02878473 |
Recruiting |
University Health Network, Toronto |
2026-01-31 |
| NCT02853474 |
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy |
https://ClinicalTrials.gov/show/NCT02853474 |
Recruiting |
Centre Oscar Lambret |
2021-10-31 |
| NCT02841800 |
Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis |
https://ClinicalTrials.gov/show/NCT02841800 |
Completed |
National Taiwan University Hospital |
2018-08-30 |
| NCT02821754 |
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) |
https://ClinicalTrials.gov/show/NCT02821754 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT02807181 |
SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Patients With Unresectable Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02807181 |
Active, not recruiting |
Sirtex Medical |
2021-06-30 |
| NCT02784795 |
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT02784795 |
Completed |
Eli Lilly and Company |
2018-08-09 |
| NCT02773485 |
Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02773485 |
Recruiting |
Tata Memorial Hospital |
2022-06-30 |
| NCT02757859 |
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02757859 |
Recruiting |
Thomas Jefferson University |
2020-08-31 |
| NCT02757391 |
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT02757391 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2024-08-01 |
| NCT02699606 |
A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02699606 |
Recruiting |
Janssen Research & Development, LLC |
2020-08-31 |
| NCT02683538 |
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies |
https://ClinicalTrials.gov/show/NCT02683538 |
Completed |
Seoul National University Hospital |
2013-07-31 |
| NCT02649712 |
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT02649712 |
Completed |
Xuzhou Central Hospital |
2018-10-31 |
| NCT02646514 |
Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study |
https://ClinicalTrials.gov/show/NCT02646514 |
Recruiting |
Yonsei University |
2019-09-30 |
| NCT02626312 |
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function |
https://ClinicalTrials.gov/show/NCT02626312 |
Recruiting |
M.D. Anderson Cancer Center |
2022-02-28 |
| NCT02609958 |
ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy |
https://ClinicalTrials.gov/show/NCT02609958 |
Completed |
Aslan Pharmaceuticals |
2017-07-07 |
| NCT02592538 |
Endobiliary Radiofrequency Ablation With S-1 for Unresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02592538 |
Completed |
First People’s Hospital of Hangzhou |
2018-08-31 |
| NCT02591030 |
Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours |
https://ClinicalTrials.gov/show/NCT02591030 |
Recruiting |
Centre Hospitalier Universitaire de Saint Etienne |
2023-09-30 |
| NCT02585856 |
Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02585856 |
Completed |
First People’s Hospital of Hangzhou |
2018-08-31 |
| NCT02631590 |
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02631590 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-11-23 |
| NCT02232932 |
Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02232932 |
Active, not recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-09-30 |
| NCT04298021 |
DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04298021 |
Recruiting |
Seoul National University Hospital |
2021-03-31 |
| NCT04298008 |
AZD6738 Plus Durvalumab in Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04298008 |
Recruiting |
Seoul National University Hospital |
2021-03-31 |
| NCT04034238 |
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors |
https://ClinicalTrials.gov/show/NCT04034238 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-01 |
| NCT02520141 |
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02520141 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT02512692 |
90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02512692 |
Recruiting |
Medical University of South Carolina |
2020-08-31 |
| NCT02496741 |
Metformin And Chloroquine in IDH1/2-mutated Solid Tumors |
https://ClinicalTrials.gov/show/NCT02496741 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2019-11-18 |
| NCT02495896 |
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT02495896 |
Active, not recruiting |
University of Southern California |
2020-02-28 |
| NCT02482454 |
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02482454 |
Active, not recruiting |
The First People’s Hospital of Changzhou |
2030-07-31 |
| NCT02468076 |
Radiofrequency Ablation for Biliopancreatic Malignancy |
https://ClinicalTrials.gov/show/NCT02468076 |
Completed |
Universitaire Ziekenhuizen Leuven |
2016-03-31 |
| NCT02456714 |
Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02456714 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2018-10-01 |
| NCT02428855 |
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02428855 |
Completed |
Massachusetts General Hospital |
2018-02-28 |
| NCT02393248 |
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) |
https://ClinicalTrials.gov/show/NCT02393248 |
Recruiting |
Incyte Corporation |
2020-07-31 |
| NCT02392637 |
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers |
https://ClinicalTrials.gov/show/NCT02392637 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT02375880 |
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder |
https://ClinicalTrials.gov/show/NCT02375880 |
Completed |
Leap Therapeutics, Inc. |
2018-07-31 |
| NCT02351765 |
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT02351765 |
Completed |
The Christie NHS Foundation Trust |
2019-03-31 |
| NCT02333188 |
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02333188 |
Completed |
University of Chicago |
2017-12-31 |
| NCT02273739 |
Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation |
https://ClinicalTrials.gov/show/NCT02273739 |
Completed |
Celgene |
2016-06-30 |
| NCT02232633 |
A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer |
https://ClinicalTrials.gov/show/NCT02232633 |
Active, not recruiting |
Boston Biomedical, Inc |
2019-02-19 |
| NCT02027311 |
Etomidate vs. Midazolam for Sedation During ERCP |
https://ClinicalTrials.gov/show/NCT02027311 |
Completed |
Cheju Halla General Hospital |
2013-08-31 |
| NCT02181634 |
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02181634 |
Completed |
PrECOG, LLC. |
2016-09-24 |
| NCT02167711 |
Treatment for Bile Duct Cancer in the Liver |
https://ClinicalTrials.gov/show/NCT02167711 |
Active, not recruiting |
Chinese University of Hong Kong |
2021-12-31 |
| NCT02162914 |
Regorafenib Versus Placebo to Treat Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02162914 |
Active, not recruiting |
Erasme University Hospital |
2019-03-31 |
| NCT02150967 |
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02150967 |
Recruiting |
QED Therapeutics, Inc. |
2022-03-31 |
| NCT02128282 |
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02128282 |
Recruiting |
Senhwa Biosciences, Inc. |
2021-08-31 |
| NCT02108145 |
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02108145 |
Recruiting |
Fourth Military Medical University |
2021-12-31 |
| NCT02088775 |
PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer |
https://ClinicalTrials.gov/show/NCT02088775 |
Active, not recruiting |
Fox Chase Cancer Center |
2016-09-08 |
| NCT02081131 |
Pancreatic Head and Peri-ampullary Cancer Laparoscopic vs Open Surgical Treatment Trial (PLOT) |
https://ClinicalTrials.gov/show/NCT02081131 |
Completed |
GEM Hospital & Research Center |
2015-09-30 |
| NCT02073994 |
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation |
https://ClinicalTrials.gov/show/NCT02073994 |
Active, not recruiting |
Agios Pharmaceuticals, Inc. |
2021-06-30 |
| NCT01313377 |
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01313377 |
Completed |
UNICANCER |
2016-06-30 |
| NCT01290536 |
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases |
https://ClinicalTrials.gov/show/NCT01290536 |
Completed |
University of California, San Francisco |
2013-10-31 |
| NCT02053376 |
A Phase 2 Trial of Regorafenib as A Single Agent in Advanced and Metastatic Biliary Tract Carcinoma/Cholangiocarcinoma Patients Who Have Failed First-line Chemotherapy |
https://ClinicalTrials.gov/show/NCT02053376 |
Completed |
University of Pittsburgh |
2018-01-07 |
| NCT02052778 |
A Study of TAS-120 in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02052778 |
Active, not recruiting |
Taiho Oncology, Inc. |
2019-12-31 |
| NCT02042443 |
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02042443 |
Completed |
National Cancer Institute (NCI) |
2017-01-31 |
| NCT02028845 |
Loop-tipped Guidewire in Selective Biliary Cannulation |
https://ClinicalTrials.gov/show/NCT02028845 |
Completed |
Ajou University School of Medicine |
2015-12-31 |
| NCT04256980 |
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement |
https://ClinicalTrials.gov/show/NCT04256980 |
Recruiting |
Innovent Biologics (Suzhou) Co. Ltd. |
2021-04-30 |
| NCT03329950 |
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies |
https://ClinicalTrials.gov/show/NCT03329950 |
Recruiting |
Celldex Therapeutics |
2021-08-31 |
| NCT01963325 |
S-1 in Combination With Abraxane in Treating Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01963325 |
Completed |
Sun Yat-sen University |
2017-12-31 |
| NCT01954745 |
Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01954745 |
Completed |
Massachusetts General Hospital |
2015-06-30 |
| NCT01938729 |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01938729 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-09-30 |
| NCT01926236 |
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT01926236 |
Completed |
The Christie NHS Foundation Trust |
2018-01-05 |
| NCT01912053 |
Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01912053 |
Completed |
Center Eugene Marquis |
2016-12-31 |
| NCT01900158 |
A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas |
https://ClinicalTrials.gov/show/NCT01900158 |
Completed |
PCI Biotech AS |
2019-02-28 |
| NCT01888302 |
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery |
https://ClinicalTrials.gov/show/NCT01888302 |
Completed |
Mayo Clinic |
2016-06-30 |
| NCT01868490 |
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells |
https://ClinicalTrials.gov/show/NCT01868490 |
Recruiting |
Siriraj Hospital |
2020-01-30 |
| NCT01862315 |
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) |
https://ClinicalTrials.gov/show/NCT01862315 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT01766219 |
CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT01766219 |
Completed |
Wake Forest University Health Sciences |
2018-04-30 |
| NCT01752920 |
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations |
https://ClinicalTrials.gov/show/NCT01752920 |
Completed |
Basilea Pharmaceutica |
2018-09-25 |
| NCT01718327 |
A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01718327 |
Completed |
GERCOR - Multidisciplinary Oncology Cooperative Group |
2016-11-17 |
| NCT01692704 |
Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy |
https://ClinicalTrials.gov/show/NCT01692704 |
Completed |
University of Zurich |
2016-03-31 |
| NCT01673802 |
The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01673802 |
Completed |
University of Alabama at Birmingham |
2014-01-31 |
| NCT01673269 |
Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBD |
https://ClinicalTrials.gov/show/NCT01673269 |
Completed |
Texas Tech University Health Sciences Center, El Paso |
2013-10-31 |
| NCT01668134 |
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01668134 |
Completed |
Washington University School of Medicine |
2014-08-30 |
| NCT01648023 |
Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin |
https://ClinicalTrials.gov/show/NCT01648023 |
Recruiting |
University of Louisville |
2020-07-31 |
| NCT01643499 |
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01643499 |
Completed |
University of Chicago |
2016-08-28 |
| NCT01595217 |
MRCP Diagnoses EHCC Better When Combined DWI |
https://ClinicalTrials.gov/show/NCT01595217 |
Completed |
China Medical University, China |
2013-03-31 |
| NCT01534637 |
Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT01534637 |
Completed |
Wake Forest University Health Sciences |
2009-12-31 |
| NCT01525069 |
Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01525069 |
Active, not recruiting |
Washington University School of Medicine |
2018-08-08 |
| NCT01470443 |
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma |
https://ClinicalTrials.gov/show/NCT01470443 |
Active, not recruiting |
Samsung Medical Center |
2016-12-31 |
| NCT01438554 |
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01438554 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-04-30 |
| NCT01347333 |
Stereotactic Body Radiotherapy for Liver Tumors |
https://ClinicalTrials.gov/show/NCT01347333 |
Completed |
Mercy Research |
2016-09-30 |
| NCT01320254 |
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) |
https://ClinicalTrials.gov/show/NCT01320254 |
Completed |
Hannover Medical School |
2016-09-12 |
| NCT01320241 |
Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture |
https://ClinicalTrials.gov/show/NCT01320241 |
Completed |
Southeast University, China |
2012-03-31 |
| NCT04404647 |
Irreversible Electroporation of Unresectable Liver Tumors |
https://ClinicalTrials.gov/show/NCT04404647 |
Recruiting |
Aalborg University Hospital |
2025-03-30 |
| NCT04400357 |
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors |
https://ClinicalTrials.gov/show/NCT04400357 |
Recruiting |
Ruijin Hospital |
2021-05-07 |
| NCT04378023 |
Liver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangiocarcinoma. A Prospective Multicenter Study. |
https://ClinicalTrials.gov/show/NCT04378023 |
Recruiting |
Hospital Vall d’Hebron |
2025-06-01 |
| NCT04361331 |
Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04361331 |
Recruiting |
Shanghai Zhongshan Hospital |
2020-12-06 |
| NCT04337333 |
Two-in-one Covered and Uncovered Metal Stent |
https://ClinicalTrials.gov/show/NCT04337333 |
Recruiting |
Ajou University School of Medicine |
2020-12-31 |
| NCT04333927 |
Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer |
https://ClinicalTrials.gov/show/NCT04333927 |
Active, not recruiting |
Sun Yat-sen University |
2024-06-30 |
| NCT04316078 |
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT04316078 |
Recruiting |
Sheba Medical Center |
2020-07-01 |
| NCT04308174 |
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04308174 |
Recruiting |
Asan Medical Center |
2021-09-30 |
| NCT04306367 |
Study of Pembrolizumab and Olaparib in Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT04306367 |
Recruiting |
Georgetown University |
2021-12-01 |
| NCT04305288 |
Chemotherapy FOLFIRINOX in Advanced or Recurrent Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04305288 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-12-31 |
| NCT04301999 |
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC |
https://ClinicalTrials.gov/show/NCT04301999 |
Recruiting |
First People’s Hospital of Hangzhou |
2020-06-01 |
| NCT04299581 |
Cryoablation Combined With Anti-PD-1 Antibody in Patients With Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04299581 |
Recruiting |
Fudan University |
2022-05-10 |
| NCT04295317 |
PD-1 Antibody (SHR-1210) Plus Apatinib and Capecitabine in Patients With Intrahepatic Cholangiocarcinoma After Surgery |
https://ClinicalTrials.gov/show/NCT04295317 |
Recruiting |
Shanghai Zhongshan Hospital |
2021-12-31 |
| NCT04276090 |
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04276090 |
Recruiting |
University of Kentucky |
2023-05-01 |
| NCT04264260 |
Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment |
https://ClinicalTrials.gov/show/NCT04264260 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2022-07-31 |
| NCT04238715 |
A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion |
https://ClinicalTrials.gov/show/NCT04238715 |
Recruiting |
Eisai Inc. |
2022-06-30 |
| NCT04238637 |
Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC) |
https://ClinicalTrials.gov/show/NCT04238637 |
Recruiting |
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
2023-12-31 |
| NCT04233567 |
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations |
https://ClinicalTrials.gov/show/NCT04233567 |
Recruiting |
Ohio State University Comprehensive Cancer Center |
2022-12-31 |
| NCT04157985 |
Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT04157985 |
Recruiting |
University of Pittsburgh |
2021-10-31 |
| NCT04149691 |
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies |
https://ClinicalTrials.gov/show/NCT04149691 |
Recruiting |
Celon Pharma SA |
2020-07-31 |
| NCT04099888 |
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT04099888 |
Recruiting |
PCI Biotech AS |
2023-07-31 |
| NCT04078230 |
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04078230 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2025-12-31 |
| NCT04077372 |
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers |
https://ClinicalTrials.gov/show/NCT04077372 |
Recruiting |
Stanford University |
2020-09-30 |
| NCT04076761 |
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04076761 |
Recruiting |
Sunnybrook Health Sciences Centre |
2021-09-30 |
| NCT04072445 |
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04072445 |
Recruiting |
Mayo Clinic |
2021-05-15 |
| NCT04068194 |
Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies |
https://ClinicalTrials.gov/show/NCT04068194 |
Recruiting |
National Cancer Institute (NCI) |
2022-12-03 |
| NCT04066491 |
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) |
https://ClinicalTrials.gov/show/NCT04066491 |
Recruiting |
EMD Serono |
2022-11-24 |
| NCT04037007 |
Efficacy of Fistulotomy for Biliary Cannulation |
https://ClinicalTrials.gov/show/NCT04037007 |
Recruiting |
Coordinación de Investigación en Salud, Mexico |
2020-03-03 |
| NCT03996408 |
Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03996408 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-12-31 |
| NCT03982680 |
Toripalimab Combined With Gemcitabine/5–fluoropyrimidine for Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03982680 |
Recruiting |
Jiangmen Central Hospital |
2021-05-30 |
| NCT03951597 |
Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03951597 |
Active, not recruiting |
Shanghai Zhongshan Hospital |
2020-01-10 |
| NCT03943043 |
Gemcitabine + Oxaliplatin +Nab-paclitaxel in Subjects With Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT03943043 |
Recruiting |
Istituto Clinico Humanitas |
2020-05-01 |
| NCT03942328 |
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer |
https://ClinicalTrials.gov/show/NCT03942328 |
Recruiting |
Mayo Clinic |
2022-05-01 |
| NCT03907852 |
Phase 1/2 Trial of TC-210 T Cells in Patients With Advanced Mesothelin-Expressing Cancer |
https://ClinicalTrials.gov/show/NCT03907852 |
Recruiting |
TCR2 Therapeutics |
2021-06-30 |
| NCT03898895 |
COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable inTrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03898895 |
Recruiting |
Sun Yat-sen University |
2024-11-30 |
| NCT03895970 |
Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors |
https://ClinicalTrials.gov/show/NCT03895970 |
Recruiting |
Peking Union Medical College Hospital |
2020-04-01 |
| NCT03878095 |
Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors |
https://ClinicalTrials.gov/show/NCT03878095 |
Recruiting |
National Cancer Institute (NCI) |
2023-03-01 |
| NCT03872947 |
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03872947 |
Recruiting |
Toray Industries, Inc |
2021-04-30 |
| NCT03852836 |
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images |
https://ClinicalTrials.gov/show/NCT03852836 |
Recruiting |
IHU Strasbourg |
2021-02-28 |
| NCT03849469 |
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03849469 |
Recruiting |
Xencor, Inc. |
2026-09-30 |
| NCT03833661 |
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) |
https://ClinicalTrials.gov/show/NCT03833661 |
Active, not recruiting |
EMD Serono |
2020-11-09 |
| NCT03801915 |
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers |
https://ClinicalTrials.gov/show/NCT03801915 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-12-31 |
| NCT03801083 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03801083 |
Recruiting |
University of Pittsburgh |
2021-01-31 |
| NCT03796819 |
Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03796819 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-12-31 |
| NCT03792048 |
Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple’s Procedure |
https://ClinicalTrials.gov/show/NCT03792048 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-01-31 |
| NCT03781934 |
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations |
https://ClinicalTrials.gov/show/NCT03781934 |
Recruiting |
Medivir |
2021-12-31 |
| NCT03779035 |
Adjuvant Chemotherapy for Biliary Tract Cancer After Curative Resection |
https://ClinicalTrials.gov/show/NCT03779035 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2020-12-31 |
| NCT03773302 |
Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations |
https://ClinicalTrials.gov/show/NCT03773302 |
Recruiting |
QED Therapeutics, Inc. |
2023-09-30 |
| NCT03772132 |
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT03772132 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-12-31 |
| NCT03771846 |
HAIC Versus Systemic Chemotherapy for Unresectable ICC |
https://ClinicalTrials.gov/show/NCT03771846 |
Recruiting |
Sun Yat-sen University |
2022-08-01 |
| NCT03769753 |
Trial of IRE in Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03769753 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-12-31 |
| NCT03768414 |
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03768414 |
Recruiting |
Southwest Oncology Group |
2024-01-01 |
| NCT03768375 |
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT03768375 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-12-30 |
| NCT03763214 |
PTFE Stents for Treatment of Malignant Biliary Strictures |
https://ClinicalTrials.gov/show/NCT03763214 |
Recruiting |
Johann Wolfgang Goethe University Hospital |
2020-03-31 |
| NCT03708445 |
Development of a New Immunochemistry Method Using Antibodies of Proteins Related Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT03708445 |
Completed |
Gangnam Severance Hospital |
2020-01-22 |
| NCT03693807 |
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03693807 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2020-09-30 |
| NCT03684811 |
A Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 Mutation |
https://ClinicalTrials.gov/show/NCT03684811 |
Active, not recruiting |
Forma Therapeutics, Inc. |
2021-09-01 |
| NCT03679338 |
Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT03679338 |
Recruiting |
Institut Paoli-Calmettes |
2020-11-30 |
| NCT03656536 |
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302) |
https://ClinicalTrials.gov/show/NCT03656536 |
Recruiting |
Incyte Corporation |
2023-10-31 |
| NCT03633773 |
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03633773 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2023-08-31 |
| NCT03620292 |
Fluorescence Image Guided Surgery in Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03620292 |
Recruiting |
University Medical Center Groningen |
2020-04-01 |
| NCT03613168 |
Trastuzumab in HER2-positive Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT03613168 |
Recruiting |
Asan Medical Center |
2020-09-01 |
| NCT03603834 |
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03603834 |
Recruiting |
Khon Kaen University |
2023-08-31 |
| NCT03602079 |
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene |
https://ClinicalTrials.gov/show/NCT03602079 |
Recruiting |
Klus Pharma Inc. |
2020-10-31 |
| NCT03579771 |
Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT03579771 |
Recruiting |
Emory University |
2021-09-30 |
| NCT03517488 |
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03517488 |
Recruiting |
Xencor, Inc. |
2020-12-31 |
| NCT03475966 |
Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program |
https://ClinicalTrials.gov/show/NCT03475966 |
Recruiting |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2019-12-31 |
| NCT03473574 |
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients |
https://ClinicalTrials.gov/show/NCT03473574 |
Recruiting |
AIO-Studien-gGmbH |
2021-09-30 |
| NCT03447691 |
Comparison Between Volatile Anesthetic-desflurane and Total Intravenous Anesthesia With Propofol and Remifentanil on Early Recovery Quality and Long Term Prognosis of Patients Undergoing Pancreatic Cancer and Common Bile Duct Cancer Surgery |
https://ClinicalTrials.gov/show/NCT03447691 |
Recruiting |
Yonsei University |
2022-08-28 |
| NCT03422679 |
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies |
https://ClinicalTrials.gov/show/NCT03422679 |
Recruiting |
Cellestia Biotech AG |
2021-06-30 |
| NCT01267344 |
A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC |
https://ClinicalTrials.gov/show/NCT01267344 |
Completed |
National Health Research Institutes, Taiwan |
2013-12-31 |
| NCT01256047 |
Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy |
https://ClinicalTrials.gov/show/NCT01256047 |
Completed |
Chiba University |
2014-03-31 |
| NCT01256034 |
Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT01256034 |
Completed |
Chiba University |
2012-03-31 |
| NCT01253148 |
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01253148 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2015-08-31 |
| NCT01242605 |
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT01242605 |
Completed |
University College, London |
2013-03-31 |
| NCT01206049 |
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations |
https://ClinicalTrials.gov/show/NCT01206049 |
Completed |
Vejle Hospital |
2016-03-31 |
| NCT01153750 |
Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct |
https://ClinicalTrials.gov/show/NCT01153750 |
Completed |
University Hospital Dresden |
2010-03-31 |
| NCT01145248 |
Comparison of Biliary Forceps Biopsy and Brush Cytology |
https://ClinicalTrials.gov/show/NCT01145248 |
Completed |
University of Ulm |
2009-07-31 |
| NCT01134276 |
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers |
https://ClinicalTrials.gov/show/NCT01134276 |
Completed |
Seoul National University Hospital |
2013-05-31 |
| NCT01093222 |
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01093222 |
Completed |
National Cancer Institute (NCI) |
2012-09-30 |
| NCT01073839 |
Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. |
https://ClinicalTrials.gov/show/NCT01073839 |
Completed |
University of Zurich |
2015-08-31 |
| NCT01043172 |
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection |
https://ClinicalTrials.gov/show/NCT01043172 |
Completed |
National Cancer Center, Korea |
2016-12-31 |
| NCT01007552 |
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts |
https://ClinicalTrials.gov/show/NCT01007552 |
Completed |
Roswell Park Cancer Institute |
2015-05-31 |
| NCT00987766 |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
https://ClinicalTrials.gov/show/NCT00987766 |
Completed |
Vanderbilt-Ingram Cancer Center |
2013-07-31 |
| NCT00976898 |
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00976898 |
Completed |
Massachusetts General Hospital |
2017-03-31 |
| NCT00955149 |
Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC) |
https://ClinicalTrials.gov/show/NCT00955149 |
Completed |
Mayo Clinic |
2013-04-30 |
| NCT00949949 |
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy |
https://ClinicalTrials.gov/show/NCT00949949 |
Completed |
Mayo Clinic |
2014-07-31 |
| NCT00948935 |
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT00948935 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2014-09-30 |
| NCT00919061 |
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy |
https://ClinicalTrials.gov/show/NCT00919061 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-03-31 |
| NCT00869635 |
S-1 and Photodynamic Therapy in Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00869635 |
Completed |
Asan Medical Center |
2013-07-31 |
| NCT00858429 |
Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases |
https://ClinicalTrials.gov/show/NCT00858429 |
Completed |
Northwestern University |
2014-03-19 |
| NCT03774589 |
Bilioenteric Anastomosis by Magnetic Compressive Technique |
https://ClinicalTrials.gov/show/NCT03774589 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-01-31 |
| NCT04413734 |
Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT04413734 |
Recruiting |
Zhejiang University |
2022-04-22 |
| NCT04386772 |
Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04386772 |
Recruiting |
Eastern Hepatobiliary Surgery Hospital |
2022-12-31 |
| NCT03734926 |
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03734926 |
Recruiting |
Guangdong Zhongsheng Pharmaceutical Co., Ltd. |
2020-10-20 |
| NCT02881554 |
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery |
https://ClinicalTrials.gov/show/NCT02881554 |
Recruiting |
University of Washington |
2022-06-01 |
| NCT01825603 |
ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01825603 |
Completed |
University of Nebraska |
2017-06-30 |
| NCT01642875 |
Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy |
https://ClinicalTrials.gov/show/NCT01642875 |
Recruiting |
Medical University of Warsaw |
2019-12-31 |
| NCT02568267 |
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) |
https://ClinicalTrials.gov/show/NCT02568267 |
Recruiting |
Hoffmann-La Roche |
2022-12-01 |
| NCT04175912 |
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver |
https://ClinicalTrials.gov/show/NCT04175912 |
Recruiting |
National Cancer Institute (NCI) |
2022-10-01 |
| NCT03940378 |
Treatment of Advanced Intrahepatic Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03940378 |
Recruiting |
The First Affiliated Hospital of Zhengzhou University |
2023-02-01 |
| NCT03104569 |
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03104569 |
Recruiting |
Hepatopancreatobiliary Surgery Institute of Gansu Province |
2021-04-01 |
| NCT03307538 |
Stereotactic Body Radiation Therapy for Unresectable Perihilar Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT03307538 |
Recruiting |
Erasmus Medical Center |
2018-11-30 |
| NCT02836847 |
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT02836847 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2019-12-31 |
| NCT02659852 |
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT02659852 |
Recruiting |
Yonsei University |
2020-01-31 |
| NCT03644173 |
Personal Resilience Empowerment Program Study |
https://ClinicalTrials.gov/show/NCT03644173 |
Active, not recruiting |
Hackensack Meridian Health |
2020-09-30 |
| NCT02834013 |
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
https://ClinicalTrials.gov/show/NCT02834013 |
Recruiting |
National Cancer Institute (NCI) |
2021-08-31 |
| NCT02170090 |
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT02170090 |
Recruiting |
Universitätsklinikum Hamburg-Eppendorf |
2021-04-30 |
| NCT00789958 |
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct |
https://ClinicalTrials.gov/show/NCT00789958 |
Completed |
Southwest Oncology Group |
2014-12-31 |
| NCT00779454 |
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00779454 |
Completed |
Vejle Hospital |
2016-03-31 |
| NCT00753675 |
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00753675 |
Completed |
Sanofi |
2012-09-30 |
| NCT00733200 |
Surgical Treatment of Hilar Cholangiocarcinoma: Minor or Major Liver Resection? |
https://ClinicalTrials.gov/show/NCT00733200 |
Completed |
Huazhong University of Science and Technology |
NA |
| NCT00721175 |
Efficacy and Cost Analysis of Plastic Stent Compare to Metallic Stent in Hilar Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00721175 |
Completed |
Khon Kaen University |
2010-04-30 |
| NCT00660699 |
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers |
https://ClinicalTrials.gov/show/NCT00660699 |
Completed |
Washington University School of Medicine |
2010-09-30 |
| NCT00660140 |
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00660140 |
Completed |
Washington University School of Medicine |
2007-01-31 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00639314 |
Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT00639314 |
Completed |
Wakayama Medical University |
2009-05-31 |
| NCT00628186 |
Randomized Controlled Trial on Pancreatic Stent Tube in Pancreaticoduodenectomy |
https://ClinicalTrials.gov/show/NCT00628186 |
Completed |
Wakayama Medical University |
2007-08-31 |
| NCT00553332 |
Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00553332 |
Completed |
National Cancer Institute (NCI) |
2013-01-31 |
| NCT00544193 |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00544193 |
Completed |
City of Hope Medical Center |
2012-08-31 |
| NCT00513539 |
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00513539 |
Completed |
University College, London |
2009-12-31 |
| NCT00486356 |
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00486356 |
Completed |
University of Nebraska |
2010-01-31 |
| NCT00465023 |
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases |
https://ClinicalTrials.gov/show/NCT00465023 |
Completed |
Massachusetts General Hospital |
2013-09-30 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00363584 |
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00363584 |
Completed |
National Cancer Institute (NCI) |
2013-08-31 |
| NCT00356889 |
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors |
https://ClinicalTrials.gov/show/NCT00356889 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00350961 |
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00350961 |
Completed |
Rigshospitalet, Denmark |
NA |
| NCT00350753 |
Avastin and Tarceva for Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00350753 |
Completed |
Rigshospitalet, Denmark |
2009-06-30 |
| NCT00338988 |
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00338988 |
Completed |
M.D. Anderson Cancer Center |
2009-05-31 |
| NCT00304135 |
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00304135 |
Completed |
Federation Francophone de Cancerologie Digestive |
2012-12-31 |
| NCT00280709 |
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT00280709 |
Completed |
University Hospital, Linkoeping |
2008-10-31 |
| NCT00266097 |
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00266097 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2009-03-31 |
| NCT00262769 |
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors |
https://ClinicalTrials.gov/show/NCT00262769 |
Completed |
University College, London |
2008-08-31 |
| NCT00238212 |
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00238212 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00230347 |
Evaluation of Stereotactic Radiosurgery For Liver Malignancies |
https://ClinicalTrials.gov/show/NCT00230347 |
Completed |
Stanford University |
2007-01-31 |
| NCT00183846 |
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00183846 |
Completed |
University of Southern California |
2007-10-31 |
| NCT00168987 |
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors |
https://ClinicalTrials.gov/show/NCT00168987 |
Completed |
Charite University, Berlin, Germany |
2006-11-30 |
| NCT00107536 |
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00107536 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00101036 |
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00101036 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00003557 |
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00003557 |
Completed |
University of Chicago |
2000-06-30 |
| NCT00084942 |
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder |
https://ClinicalTrials.gov/show/NCT00084942 |
Completed |
Roswell Park Cancer Institute |
2004-05-31 |
| NCT00004604 |
Biological Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004604 |
Completed |
Duke University |
2001-06-30 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00005938 |
DX-8951f in Treating Patients With Biliary Cancer |
https://ClinicalTrials.gov/show/NCT00005938 |
Completed |
Daiichi Sankyo, Inc. |
2005-04-30 |
| NCT00019474 |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer |
https://ClinicalTrials.gov/show/NCT00019474 |
Completed |
Montefiore Medical Center |
2000-08-31 |
| NCT00003411 |
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT00003411 |
Completed |
University of Pittsburgh |
2002-06-30 |
| NCT00003923 |
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas |
https://ClinicalTrials.gov/show/NCT00003923 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-02-28 |
| NCT00009893 |
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00009893 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-01-31 |
| NCT00073905 |
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00073905 |
Completed |
Swiss Group for Clinical Cancer Research |
2006-06-30 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00033462 |
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00033462 |
Completed |
National Cancer Institute (NCI) |
2006-11-30 |
| NCT00004910 |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction |
https://ClinicalTrials.gov/show/NCT00004910 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00004895 |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00004895 |
Completed |
Northwestern University |
2002-10-31 |
| NCT00059865 |
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00059865 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-02-28 |
| NCT00033540 |
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00033540 |
Completed |
Southwest Oncology Group |
2008-04-30 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00028496 |
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00028496 |
Completed |
National Cancer Institute (NCI) |
2005-11-30 |
| NCT00021047 |
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor |
https://ClinicalTrials.gov/show/NCT00021047 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00019513 |
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00019513 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041808 |
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver |
https://ClinicalTrials.gov/show/NCT00041808 |
Completed |
FeRx |
NA |